Qube Research & Technologies LTD Simulations Plus, Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 15,913 shares of SLP stock, worth $505,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,913
Previous 14,275
11.47%
Holding current value
$505,556
Previous $456,000
2.85%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SLP
# of Institutions
172Shares Held
15.7MCall Options Held
11.1KPut Options Held
7.3K-
Black Rock Inc. New York, NY2.46MShares$78.3 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC2.23MShares$70.7 Million0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$36.4 Million0.0% of portfolio
-
State Street Corp Boston, MA721KShares$22.9 Million0.0% of portfolio
-
Ranger Investment Management, L.P. Dallas, TX702KShares$22.3 Million1.27% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $645M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...